JP2015522036A5 - - Google Patents

Download PDF

Info

Publication number
JP2015522036A5
JP2015522036A5 JP2015520627A JP2015520627A JP2015522036A5 JP 2015522036 A5 JP2015522036 A5 JP 2015522036A5 JP 2015520627 A JP2015520627 A JP 2015520627A JP 2015520627 A JP2015520627 A JP 2015520627A JP 2015522036 A5 JP2015522036 A5 JP 2015522036A5
Authority
JP
Japan
Prior art keywords
alkyl
halogen
cycloalkyl
compound according
item
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
JP2015520627A
Other languages
English (en)
Japanese (ja)
Other versions
JP2015522036A (ja
JP6109934B2 (ja
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/US2013/048950 external-priority patent/WO2014008197A1/en
Publication of JP2015522036A publication Critical patent/JP2015522036A/ja
Publication of JP2015522036A5 publication Critical patent/JP2015522036A5/ja
Application granted granted Critical
Publication of JP6109934B2 publication Critical patent/JP6109934B2/ja
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

JP2015520627A 2012-07-03 2013-07-01 脂質合成の複素環モジュレーター Active JP6109934B2 (ja)

Applications Claiming Priority (9)

Application Number Priority Date Filing Date Title
US201261667894P 2012-07-03 2012-07-03
US61/667,894 2012-07-03
US201261698511P 2012-09-07 2012-09-07
US61/698,511 2012-09-07
US201261699819P 2012-09-11 2012-09-11
US61/699,819 2012-09-11
US201361785933P 2013-03-14 2013-03-14
US61/785,933 2013-03-14
PCT/US2013/048950 WO2014008197A1 (en) 2012-07-03 2013-07-01 Heterocyclic modulators of lipid synthesis

Publications (3)

Publication Number Publication Date
JP2015522036A JP2015522036A (ja) 2015-08-03
JP2015522036A5 true JP2015522036A5 (enExample) 2016-08-18
JP6109934B2 JP6109934B2 (ja) 2017-04-05

Family

ID=48790663

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2015520627A Active JP6109934B2 (ja) 2012-07-03 2013-07-01 脂質合成の複素環モジュレーター

Country Status (17)

Country Link
US (3) US9428502B2 (enExample)
EP (1) EP2870150B1 (enExample)
JP (1) JP6109934B2 (enExample)
KR (1) KR102071095B1 (enExample)
CN (1) CN104507928B (enExample)
AU (2) AU2013286894B2 (enExample)
BR (1) BR112015000106B1 (enExample)
CA (1) CA2877999C (enExample)
ES (1) ES2738823T3 (enExample)
IL (1) IL236407A (enExample)
IN (1) IN2015DN00137A (enExample)
MX (1) MX364815B (enExample)
NZ (2) NZ703162A (enExample)
PL (1) PL2870150T3 (enExample)
SG (1) SG11201500024YA (enExample)
WO (1) WO2014008197A1 (enExample)
ZA (1) ZA201409477B (enExample)

Families Citing this family (28)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20170119786A1 (en) 2011-03-08 2017-05-04 3-V Biosciences, Inc. Heterocyclic modulators of lipid synthesis
US9624173B2 (en) * 2011-03-08 2017-04-18 3-V Biosciences, Inc. Heterocyclic modulators of lipid synthesis
TWI522348B (zh) * 2011-03-08 2016-02-21 3 V生物科技公司 脂質合成之雜環調節劑
CA2877999C (en) 2012-07-03 2021-02-23 3-V Biosciences, Inc. Heterocyclic modulators of lipid synthesis
EP3083583B1 (en) * 2013-12-20 2020-11-18 Sagimet Biosciences Inc. Heterocyclic modulators of lipid synthesis and combinations thereof
EP3092232B1 (en) 2014-01-07 2022-03-09 Sagimet Biosciences Inc. Heterocyclic modulators of lipid synthesis for use against cancer and viral infections
JP6691909B2 (ja) * 2014-08-15 2020-05-13 サギメット バイオサイエンシーズ インコーポレイテッド 薬物耐性癌の治療で用いるための脂肪酸シンターゼ阻害剤
WO2016028971A1 (en) * 2014-08-21 2016-02-25 Bristol-Myers Squibb Company Tied-back benzamide derivatives as potent rock inhibitors
ES2727158T3 (es) 2014-12-03 2019-10-14 Janssen Pharmaceutica Nv Ligandos para PET de mGluR2 radiomarcados
EP3277675B1 (en) 2015-03-19 2022-01-19 Sagimet Biosciences Inc. Heterocyclic modulators of lipid synthesis
JP2018083758A (ja) * 2015-03-25 2018-05-31 旭硝子株式会社 ピラゾール誘導体の製造方法
MX379846B (es) 2015-06-18 2025-03-11 89Bio Ltd Derivados de 4-bencil y 4-benzoil piperidina sustituidos.
ES2821049T3 (es) 2015-06-18 2021-04-23 89Bio Ltd Derivados de piperidina 1,4 sustituidos
US11045562B2 (en) 2015-12-18 2021-06-29 Janssen Pharmaceutica Nv Radiolabelled mGluR2/3 PET ligands
WO2017103182A1 (en) 2015-12-18 2017-06-22 Janssen Pharmaceutica Nv Radiolabelled mglur2/3 pet ligands
KR20180105161A (ko) 2016-01-07 2018-09-27 씨에스 파마테크 리미티드 Egfr 티로신 키나제의 임상적으로 중요한 돌연변이체의 선택적 억제제
WO2017119732A1 (en) 2016-01-08 2017-07-13 Samsung Electronics Co., Ltd. Electronic device and operating method thereof
CN108884445A (zh) 2016-03-09 2018-11-23 北京智康博药肿瘤医学研究有限公司 肿瘤细胞悬浮培养物和相关方法
JP7668509B2 (ja) * 2016-11-11 2025-04-25 サギメット バイオサイエンシーズ インコーポレイテッド 脂質合成の複素環式モジュレーター
CN107954852A (zh) * 2017-11-30 2018-04-24 贝利化学(张家港)有限公司 2,5-二卤代苯甲酸的制备方法
WO2020135483A1 (en) 2018-12-26 2020-07-02 Janssen Pharmaceutica Nv Thienopyridinone compounds
US20220400732A1 (en) * 2019-03-21 2022-12-22 Cornell University Anti-fructose therapy for colorectal and small intestine cancers
CN111592495A (zh) * 2020-07-06 2020-08-28 上海启讯医药科技有限公司 一种2-正丁基-4-氯-5甲酰基咪唑的制备方法
CN114988975A (zh) * 2022-06-28 2022-09-02 江苏科技大学 一种基于有机染料催化的β-三氟甲基烯胺化合物的制备方法
CN116482278B (zh) * 2023-05-06 2024-02-09 广州清瑞生物科技有限责任公司 一种用于检测阿昔洛韦的对照品的制备方法
CN119080742A (zh) * 2023-06-05 2024-12-06 甘莱制药有限公司 脂质合成的杂环调节剂的工业化制备
WO2025086054A1 (zh) * 2023-10-23 2025-05-01 歌礼生物科技(杭州)有限公司 一种包含苯甲腈衍生物的药物组合物
WO2025120168A1 (en) 2023-12-07 2025-06-12 Institut National De Recherche Pour L'agriculture, L'alimentation Et L'environnement (Inrae) Sulfonamide derivatives and use thereof in the treatment of cryptosporidium infections

Family Cites Families (15)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
PL1959951T3 (pl) 2005-12-01 2010-06-30 Hoffmann La Roche Heteroarylo-podstawione pochodne piperydyny jako inhibitory l-cpt1
AU2007292306A1 (en) 2006-09-05 2008-03-13 Bipar Sciences, Inc. Inhibition of fatty acid synthesis by PARP inhibitors and methods of treatment thereof
WO2008059214A1 (en) * 2006-11-13 2008-05-22 Astrazeneca Ab Bisamlde derivatives and use thereof as fatty acid synthase inhibitors
TW200833663A (en) * 2006-12-21 2008-08-16 Astrazeneca Ab Therapeutic agents
WO2008075077A1 (en) 2006-12-21 2008-06-26 Astrazeneca Ab Piperidine derivatives for the treatment of obesity
TW200831092A (en) * 2006-12-21 2008-08-01 Astrazeneca Ab Therapeutic agents
TWI522348B (zh) 2011-03-08 2016-02-21 3 V生物科技公司 脂質合成之雜環調節劑
US9624173B2 (en) * 2011-03-08 2017-04-18 3-V Biosciences, Inc. Heterocyclic modulators of lipid synthesis
HUE032459T2 (en) 2011-03-08 2017-09-28 3-V Biosciences Inc Heterocyclic modulators of lipid synthesis
US20170119786A1 (en) * 2011-03-08 2017-05-04 3-V Biosciences, Inc. Heterocyclic modulators of lipid synthesis
CA2877999C (en) 2012-07-03 2021-02-23 3-V Biosciences, Inc. Heterocyclic modulators of lipid synthesis
EP3083583B1 (en) * 2013-12-20 2020-11-18 Sagimet Biosciences Inc. Heterocyclic modulators of lipid synthesis and combinations thereof
EP3092232B1 (en) * 2014-01-07 2022-03-09 Sagimet Biosciences Inc. Heterocyclic modulators of lipid synthesis for use against cancer and viral infections
JP6691909B2 (ja) * 2014-08-15 2020-05-13 サギメット バイオサイエンシーズ インコーポレイテッド 薬物耐性癌の治療で用いるための脂肪酸シンターゼ阻害剤
EP3277675B1 (en) * 2015-03-19 2022-01-19 Sagimet Biosciences Inc. Heterocyclic modulators of lipid synthesis

Similar Documents

Publication Publication Date Title
JP2015522036A5 (enExample)
JP2013544860A5 (enExample)
AR089134A1 (es) Arilos y heteroarilos biciclicos inhibidores de los canales de sodio
JP2017505291A5 (enExample)
JP2013545816A5 (enExample)
JP2016517417A5 (enExample)
RU2477723C2 (ru) Ингибиторы протеинкиназ (варианты), их применение для лечения онкологических заболеваний и фармацевтическая композиция на их основе
JP2013545818A5 (enExample)
JP2013545817A5 (enExample)
JP2020530487A5 (enExample)
JP2010536887A5 (enExample)
JP2013523802A5 (enExample)
JP2013537203A5 (enExample)
JP2014510727A5 (enExample)
JP2010031025A5 (enExample)
JP2010522765A5 (enExample)
JP2008503591A5 (enExample)
JP2019518766A5 (enExample)
JP2013531029A5 (enExample)
CN111868026A (zh) 含有n杂五元环的衣壳蛋白装配抑制剂、其药物组合物和用途
RU2010114828A (ru) Производные урацила или тимина для лечения гепатита с
JP2017504576A5 (enExample)
JP2010518128A5 (enExample)
JP2017537949A5 (enExample)
JP2011509309A5 (enExample)